|
Fluphenazine Decanoate
» Fluphenazine Decanoate contains not less than 98.0 percent and not more than 102.0 percent of C32H44F3N3O2S, calculated on the dried basis.
Packaging and storage
Preserve in tight, light-resistant containers.
USP Reference standards
USP Fluphenazine Decanoate Dihydrochloride RS.
noteThroughout the following procedures, protect test or assay specimens, the USP Reference Standard, and solutions containing them, by conducting the procedures without delay, under subdued light, or using low-actinic glassware.
Identification
A:
Place about 50 mg of Fluphenazine Decanoate and about 50 mg of USP Fluphenazine Decanoate Dihydrochloride RS in separate, glass-stoppered, small centrifuge tubes, and treat each tube as follows. Add 1.5 mL of sodium hydroxide solution (1 in 250), and mix. Add 2 mL of carbon disulfide, shake vigorously for 2 minutes, and centrifuge. Dry the lower, clear layer by filtering through 2 g of anhydrous sodium sulfate: the IR absorption spectrum of the test preparation, determined in a 0.1-mm cell, exhibits maxima only at the same wavelengths as that of the Standard preparation, similarly measured.
B:
Use a suitable thin-layer chromatographic plate (see Chromatography
Loss on drying
Residue on ignition
Ordinary impurities
Test solution:
methanol.
Standard solution:
methanol.
Eluant
: a mixture of acetone, cyclohexane, and ammonium hydroxide (16:6:1).
Visualization:
1; then spray the plate with 50% sulfuric acid.
Interpretation:
no individual ordinary impurity observed exceeds 1.0% and the total of any ordinary impurities observed does not exceed 2.0%.
Assay
Dissolve about 500 mg of Fluphenazine Decanoate, accurately weighed, in 50 mL of glacial acetic acid, add one drop of crystal violet TS, and titrate with 0.1 N perchloric acid VS to a blue-green endpoint. Perform a blank determination, and make any necessary correction. Each mL of 0.1 N perchloric acid is equivalent to 29.59 mg of C32H44F3N3O2S.
Auxiliary Information
Please check for your question in the FAQs before contacting USP.
USP32NF27 Page 2421
Pharmacopeial Forum: Volume No. 29(6) Page 1887
|